A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial

BACKGROUND: A subset of COPD-patients presents with eosinophilic airway inflammation. While treatment of asthmatic patients with the GATA3-specific DNAzyme SB010 attenuated sputum eosinophilia after allergen challenge, this specific treatment has not been evaluated in patients with COPD. Our objecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Greulich, Timm, Hohlfeld, Jens M., Neuser, Petra, Lueer, Katrin, Klemmer, Andreas, Schade-Brittinger, Carmen, Harnisch, Susanne, Garn, Holger, Renz, Harald, Homburg, Ursula, Renz, Jonas, Kirsten, Anne, Pedersen, Frauke, Müller, Meike, Vogelmeier, Claus F., Watz, Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883532/
https://www.ncbi.nlm.nih.gov/pubmed/29615049
http://dx.doi.org/10.1186/s12931-018-0751-x

Ejemplares similares

Ejemplares similares